Bharat Biotech
Search results
Latest News. Indian Immunologicals unveils indigenously developed Hepatitis A vaccine. 19 January 2024. Indian Immunologicals launches measles and rubella vaccine for children. 25November 2023.
Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products. IIL operates one of the largest plants in the world for veterinary vaccines.
Indian Immunologicals Limited (IIL) is a subsidiary of the National Dairy Development Board. It is based in Hyderabad, Telangana, India. IIL is registered in India as a Public Limited Company under the Companies Act, 1956 (Ministry of Corporate Affairs – MCA Services), It was established in 1982 by the National Dairy Development Board.
Indian Immunologicals Ltd. (IIL) National Dairy Development Board (NDDB) established Indian Immunologicals as a unit in 1982 with the objective of manufacturing vaccines and providing to customers at an affordable price.
National Dairy Development Board (NDDB) established Indian Immunologicals Ltd. (IIL) in 1982 with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price.
Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products. IIL operates one of the largest plants in the world for...
Feb 4, 2024 · Indian Immunologicals Ltd (IIL) is the leading animal and human vaccine manufacturer in India and offers rabies, Hepatitis B, Diptheria, and influenza vaccines. Indian Immunologicals was setup by The National Dairy Development Board (NDDB) in 1982, as its unit, with the objective of making vaccines available to farmers at an affordable price.
Mar 18, 2024 · Indian Immunologicals Limited aims to release dengue vaccine by mid-2026 after successful phase 1 trials.
Dec 19, 2021 · Indian Immunologicals Ltd (IIL) has launched Goat Pox Vaccine (Raksha Goat Pox) which is expected to help Control of Goat Pox disease.
Aug 24, 2023 · Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top executive said, as the race to develop the country's first...
